© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Personal reflections on efforts to reduce ischemic myocardial damage
Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
* Tel.: +1-617-732-8989; fax: +1-617-975-0955. ebraunwald@partners.org
Received 14 August 2002; accepted 20 August 2002
| The first 150 words of the full text of this article appear below. |
| 1 Background |
|---|
In the second half of the 19th Century, physiologists observed that ligation of a major coronary artery in the dog was immediately fatal. During that era, pathologists occasionally encountered thrombosis of such vessels and acute myocardial infarction (AMI) at autopsy, and considered this combination of findings to be quite uncommon and uniformly fatal. At the dawn of the twentieth century, Krehl, a Viennese physician, challenged these beliefs and reported that coronary thrombosis was actually compatible with survival [1]. In 1910, Obrastov and Strazheske [2], two Russian physicians, and in 1912, Herrick, a Chicago physician [3], described the clinical features of AMI, related them to the pathologic findings and distinguished AMI from angina pectoris. Herrick also adapted the then new technique of electrocardiography to the premorbid diagnosis of AMI, considered at the time to be a very uncommon condition.
By the middle of the 20th Century, during my
| 2 Early research |
|---|
| 3 The reduction of ischemia by carotid nerve stimulation |
|---|
| 4 Early efforts to reduce ischemic damage |
|---|
| 5 Clinical myocardial reperfusion |
|---|
| 6 The TIMI trials |
|---|
| 7 Stunning and hibernation |
|---|
| 8 ACE inhibitors and statins |
|---|
| 9 Conclusions |
|---|
This article has been cited by other articles:
![]() |
P.J. Devereaux, L. Goldman, D. J. Cook, K. Gilbert, K. Leslie, and G. H. Guyatt Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk Can. Med. Assoc. J., September 13, 2005; 173(6): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Madias The Impact of Systemic BP on Coronary Blood Flow and Infarct Size During Reperfusion Therapy for Acute Myocardial Infarction: Refinements Beyond the "Plumbing" Chest, April 1, 2004; 125(4): 1179 - 1181. [Full Text] [PDF] |
||||
![]() |
J.-i. Oyama, C. Blais Jr, X. Liu, M. Pu, L. Kobzik, R. A. Kelly, and T. Bourcier Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice Circulation, February 17, 2004; 109(6): 784 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J L DeJongste, R. A Tio, and R. D Foreman Chronic therapeutically refractory angina pectoris Heart, February 1, 2004; 90(2): 225 - 230. [Full Text] [PDF] |
||||



